Breathalyzers
Exhaled breath tests have proved hard to deliver - Jop de Vrieze
image by: Lidiia Moor
HWN Recommends
Frisco Startup Lands First U.S. Authorization for COVID-19 Breathalyzer Test
The InspectIR test uses a technique that can rapidly identify organic compounds associated with the virus. According to results from a study of about 2,400 people, the InspectIR breathalyzer correctly identified 91.2% positive samples of COVID-19 and 99.3% of negative samples. That means that the tests are more effective than the rapid antigen tests available for free through the government, but slightly lower than the nearly 100% effectiveness of current PCR tests. However, it is less invasive than the procedures for both.
Resources
This Breath Test Can Detect Whether You Have COVID-19 in Just 3 Minutes
But how accurate will the results be? The COVID-19 breath test was used in a study of 2,409 patients, a group that included those with and without COVID-19 symptoms. The breathalyzer correctly identified 91% of positive samples and 99% of negative samples. Even so, the FDA says that all positive results from a breathalyzer test should be confirmed with a molecular test,
A New Covid Breath Test Holds Promise, but Wide Use May Still Be Far Off
The F.D.A. authorized a breath-based test made by a small Texas company, which said it hoped that mobile sites could use the device.
Forget throat swabs: Dutch company claims its breathalyzer can help sniff out COVID-19
New device looks for signature mix of volatile compounds in patients' exhaled air.
Meet The Founders Of The $2.7 Million Startup Behind The New Covid Breathalyzer
The main benefit for consumers are twofold: one, there’s no nose swab involved. Two, the tests were also found to be highly accurate.
The COVID Breathalyzers Are Coming
Developed by a company in Texas called InspectIR that specializes in portable opioid- and cannabis-detection devices, its COVID-19 Breathalyzer will be used in places where tests are collected and analyzed, including doctor’s offices, hospitals, and mobile sites.
The FDA just authorized a 10-second breath test for COVID
The breathalyzer can give back results in three minutes, but has to be performed by a health care professional.
Frisco Startup Lands First U.S. Authorization for COVID-19 Breathalyzer Test
Frisco-based InspectIR received the FDA emergency use authorization on Friday for its breathalyzer test, which tests for organic compounds associated with COVID-19 in a person's breath. According to a study, the tests are more effective than the rapid antigen tests available for free from the U.S. government.
InspectIR Systems
A research, development & device company focused on portable COVID-19 diagnostic screening applications.
Related Articles
©2022 | HealthWorldNet, Inc. | 116864
Last Updated : Saturday, April 30, 2022